IBBQ: This Low-Cost Biotech ETF Comes With Unique Risks
IBBQ is a relatively new US biotech ETF that competes with established peers like IBB and XBI. Read why I don't recommend ...
Gilead Sciences Unusual Options Activity For September 20
Today, Benzinga's options scanner spotted 9 options trades for Gilead Sciences. This is not a typical pattern. The sentiment ...
Ideaya Biosciences Advances Synthetic Lethality With IDE397 Success
IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.
High Growth Tech Stocks To Watch This September 2024
As global markets rebound from recent sell-offs, with growth stocks notably outpacing value shares, the technology sector has ...
bovnews3d
Gilead Sciences, Inc. (GILD) Stock: Unveiling Its Hidden Strengths
Raymond James has recently raised Gilead Sciences, Inc. (GILD) stock to Outperform rating, as announced on July 8, 2024, according to Finviz. Earlier, on May 1, 2024, Maxim Group had reiterated the ...
Pharmaceutical Drug Delivery Market to Hit USD 2,546 Billion by 2029 | MarketsandMarkets™
The global pharmaceutical drug delivery market is set to grow from USD 1,949.4 billion in 2024 to USD 2,546.0 billion by 2029 ...
Cell Therapy Manufacturing Market Historical Trends (2022-2023) and Forecasted Estimates (2024-2035)
The "Cell Therapy Manufacturing Market (6th Edition): Industry Trends and Global Forecasts to 2035 - Distribution by Type of Cell Therapy, Source of Cells, Scale of Operation, Type of Manufacturer and ...